Details for New Drug Application (NDA): 020035
✉ Email this page to a colleague
The generic ingredient in ERGAMISOL is levamisole hydrochloride. There are three drug master file entries for this compound. Additional details are available on the levamisole hydrochloride profile page.
Summary for 020035
Tradename: | ERGAMISOL |
Applicant: | Janssen Pharma |
Ingredient: | levamisole hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020035
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Jun 18, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 020035
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharma | ERGAMISOL | levamisole hydrochloride | TABLET;ORAL | 020035-001 | Jun 18, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription